can be removed by cough or mechanical aspiration). (2, 4, 5, 11, 13, (15) (16) (17) (18) 26, 29, 36, 37) Each position consists of placing the target lung segment(s) superior to the carina. Positions should generally be held for 3 to 15 minutes (longer in special situations). (4, 6, 13, 16, 18, 20, 29, (38) (39) (40) Standard positions are modified as the patient's condition and tolerance warrant.
External Manipulation of the Thorax

Percussion
Percussion is also referred to as cupping, clapping, and tapotement. The purpose of percussion is to intermittently apply kinetic energy to the chest wall and lung. This is accomplished by rhythmically striking the thorax with cupped hand or mechanical device directly over the lung segment(s) being drained. No convincing evidence demonstrates the superiority of one method over the other. (4, 18, (41) (42) (43) (44) 
Vibration
Vibration involves the application of a fine tremorous action (manually performed by pressing in the direction that the ribs and soft tissue of the chest move during expiration) over the draining area. No conclusive evidence supports the efficacy of vibration, the superiority of either manual or mechanical methods, or an optimum frequency. (2, 4, 13, 27, 28, 30, 36, 38, 39, (45) (46) (47) PDT 3.0 SETTING:
Although PDT can be used with neonates, infants, childrens, and adults, this Guideline applies primarily to older children and adults. PDT 7.1 Presumed effectiveness of PDT and its application may be based more on tradition and anecdotal report than on scientific evidence. The procedure has been used excessively and in patients in whom it is not indicated. (11, 40, (61) (62) (63) 7.2 Airway clearance may be less than optimal in patients with ineffective cough. 7.3 Optimal positioning is difficult in critically ill patients.
PDT 8.0 ASSESSMENT OF NEED:
The following should be assessed together to establish a need for postural drainage therapy 8.1 excessive sputum production 8.2 effectiveness of cough 8.3 history of pulmonary problems treated successfully with PDT (eg, bronchiectasis, cystic fibrosis, lung abscess) 8.4 decreased breath sounds or crackles or rhonchi suggesting secretions in the airway 8.5 change in vital signs 8. 6 Abnormal chest x-ray consistent with atelectasis, mucus plugging, or infiltrates 8.7 deterioration in arterial blood gas values or oxygen saturation PDT 9.0 ASSESSMENT OF OUTCOME:
These represent individual criteria that indicate a positive response to therapy (and support continuation of therapy). Not all criteria are required to justify continuation of therapy (eg, a ventilated patient may not have sputum production > 30 mL/day, but have improvement
R E T I R E D
in breath sounds, chest x-ray, or increased compliance or decreased resistance).
Change in sputum production
If sputum production in an optimally hydrated patient is less than 25 mL/day with PDT the procedure is not justified. (3,5,7,9,11,12,38,40 ,46,51-53) Some patients have productive coughs with sputum production from 15 to 30 mL/day (occasionally as high as 70 or 100 mL/day) without postural drainage. If postural drainage does not increase sputum in a patient who produces > 30 mL/day of sputum without postural drainage, the continuation of the therapy is not indicated. Because sputum production is affected by systemic hydration, apparently ineffective PDT probably should be continued for at least 24 hours after optimal hydration has been judged to be present.
Change in breath sounds of lung fields being drained
With effective therapy, breath sounds may 'worsen' following the therapy as secretions move into the larger airways and increase rhonchi. An increase in adventitious breath sounds can be a marked improvement over absent or diminished breath sounds. Note any effect that coughing may have on breath sounds. One of the favorable effects of coughing is clearing of adventitious breath sounds.
Patient subjective response to therapy
The caregiver should ask patient how he or she feels before, during, and after therapy. Feelings of pain, discomfort, shortness of breath, dizziness, and nausea should be considered in decisions to modify or stop therapy. Easier clearance of secretions and increased volume of secretions during and after treatments support continuation.
Change in vital signs
Moderate changes in respiratory rate and/or pulse rate are expected. Bradycardia, tachycardia, or an increase in irregularity of pulse, or fall or dramatic increase in blood pressure are indications for stopping therapy.
Change in chest x-ray
Resolution or improvement of atelectasis may be slow or dramatic.
Change in arterial blood gas values or oxygen saturation
Oxygenation should improve as atelectasis resolves.
Change in ventilator variables
Resolution of atelectasis and plugging reduces resistance and increases compliance. The following should be chosen as appropriate for monitoring a patient's response to postural drainage therapy, before, during, and after therapy. 11.1 Subjective response--pain, discomfort, dyspnea, response to therapy 11.2 Pulse rate, dysrhythmia, and EKG if available 11.3 Breathing pattern and rate, symmetrical chest expansion, synchronous thoracoabdom-inal movement, flail chest 11.4 Sputum production (quantity, color, consistency, odor) and cough effectiveness 11.5 Mental function 11.6 Skin color 11.7 Breath sounds 11.8 blood pressure 11.9 oxygen saturation by pulse oximetry (if hypoxemia is suspected) 11.10 intracranial pressure (ICP)
R E T I R E D PDT 12.0 FREQUENCY:
The frequencies suggested are recommendations from group experience and apply to patients in whom the therapy is indicated. Careful assessment and prudent clinical judgment must be exercised by the caregiver. 
Turning
